Parkinson's drug solengepras to be filed for approval after trial reports daily-living gains
Patients in the ARISE trial reported improvements in daily living and gained an average of 36 more minutes of "good"…
Asia Tech Times — Technology, science and culture across Asia
Peer-reviewed work, and what it means outside the lab.
69 stories Page 2 of 6
Patients in the ARISE trial reported improvements in daily living and gained an average of 36 more minutes of "good"…
Braintree Laboratories said both doses of tegoprazan met the primary and secondary endpoints of the TRIUMpH-NERD study…
Celltrion USA said the oral presentations cover subcutaneous versus intravenous infliximab in ileum-dominant Crohn's…
The Phase III COMPASSION-40/AK104-313 trial will test the PD-1/CTLA-4 bispecific antibody as monotherapy before and…
The company reported that its once-daily PDE4B inhibitor outperformed apremilast at Week 16 and is now being taken into…
The company said Europe's biologics market is projected to reach about US$269.65 billion by 2035 and pointed to its…
The format, introduced at a spatial biology conference in Spain, is intended to let researchers study more of an FFPE…
Applications close on 10 October 2026 for a three-month programme in Hyderabad on millets and other ancient grains.
The collaboration's first reported result flags samples at elevated risk of Fresh Mushroom Aroma before the defect…
The company said the presentations span prostate, urothelial, gastric, lung and pancreatic cancers, and include…
A 62-participant study in Physiological Reports is the first published evaluation of penKid for kidney functional…
The Australian graphene company will work with the Turkish prepreg manufacturer to develop and validate a carbon fibre…